EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients

Jingyi Zhong, Xiaopu Lin, Xiaobin Zheng, Yanting Zhou, Haishan Huang, Lingling Xu iD

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Jingyi Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Like Growth Factor I, Diabetic Neuropathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, the Science and Technology Planning Project of Shenzhen Municipality, the Young Scientific Talent Research Project of China Endocrinology and Metabolism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction To investigate risk factors for diabetic peripheral neuropathy (DPN) and to explore the connection between insulin‐like growth factor‐1 (IGF‐1) and DPN in individuals with type 2 diabetes. Materials and Methods A total of 790 patients with type 2 diabetes participated in a cross‐sectional study, divided into two groups: those with DPN (DPN) and those without DPN (non‐DPN). Blood samples were taken to measure IGF‐1 levels and other biochemical markers. Participants underwent nerve conduction studies and quantitative sensory testing.

Results

Patients with DPN exhibited significantly lower levels of IGF‐1 compared with non‐DPN patients ( P < 0.001). IGF‐1 was positively correlated with the average amplitude of both motor ( P < 0.05) and sensory nerves ( P < 0.05), but negatively correlated with the vibration perception threshold ( P < 0.05). No significant difference was observed between IGF‐1 and nerve conduction velocity ( P > 0.05), or the temperature detection threshold ( P > 0.05). Multivariate regression analysis identified diabetes duration, HbA 1c , and the low levels of IGF‐1 as independent risk factors ( P < 0.001). Receiver operating characteristic analysis determined that at 8 years duration of diabetes, 8.5% (69.4 mmol/mol) HbA 1c and 120 ng/mL IGF‐1, the optimal cut‐off points, indicated DPN ( P < 0.001).

Conclusions

A reduction of IGF‐1 in patients with DPN suggests a potential protective role against axon injury in large fiber nerves of type 2 diabetes patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin-Like Growth Factor IDiabetic NeuropathiesHumansMaleFemaleRisk FactorsMiddle AgedCross-Sectional StudiesAgedNeural ConductionBiomarkersInsulin-Like Peptides

Stichwörter der Autor:innen

Diabetic neuropathyInsulin‐like growth factor‐1Nerve conduction studies

Substanzen

Insulin-Like Growth Factor IIGF1 protein, humanBiomarkersInsulin-Like Peptides

Autor:innen und Institutionen

  • Department of Endocrinology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Huiqiao Medical Centre, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Lingling Xu

Förderung

  • National Natural Science Foundation of China
  • the Science and Technology Planning Project of Shenzhen Municipality
  • the Young Scientific Talent Research Project of China Endocrinology and Metabolism

Zitieren

APA

Zhong, J., Lin, X., Zheng, X., Zhou, Y., Huang, H., & Xu, L. (2024). Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14260

Vancouver

Zhong J, Lin X, Zheng X, Zhou Y, Huang H, Xu L. Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14260

BibTeX
@article{Zhong2024,
  author = {Zhong, Jingyi and Lin, Xiaopu and Zheng, Xiaobin and Zhou, Yanting and Huang, Haishan and Xu, Lingling},
  title = {Diminished levels of insulin‐like growth factor‐1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14260}
}
Kostenlos starten →